Author

Bianca Luckerbauer

Medical University of Vienna

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Anela TosevskaiD· 2 shared Michael Markus BonelliiD· 2 shared Alejandro V. VillarinoiD· 1 shared Arian D. J. LaurenceiD· 1 shared Behdad AfzaliiD· 1 shared Daniel AletahaiD· 1 shared Françoise MeylaniD· 1 shared Giuseppe SciumèiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Anela TosevskaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Preserved suppressive function despite loss of Foxp3: insights into the identity of regulatory T cells

Bianca Luckerbauer, Alejandro V. Villarino, Arian D. J. Laurence, Kiyoshi Hirahara, Giuseppe Sciumè, Yohei Mikami, HY Shih, Hong‐Wei Sun, Anela Tosevska, M Brinkmann, SR Brooks, Jörg Scheffel, Françoise Meylan, Behdad Afzali, Michael Markus Bonelli

This study shows that regulatory T cells can maintain suppressive function and a Treg signature even when Foxp3 expression is lost in Th2-driven disease models.

bioRxiv · Jan 17, 2025 · PreprintImmunology

Targeting histone acetylation enables epigenetic modulation of inflammatory pathways, a novel therapeutic strategy for rheumatoid arthritis

Marie Brinkmann, Anela Tosevska, Bianca Luckerbauer, Moritz Madern, Lisa Göschl, Wilfried Ellmeier, Daniel Aletaha, Teresa Preglej, Michael Markus Bonelli

This study screens histone acetylation inhibitors to modulate immune pathways in RA, showing concentration-dependent effects and overlap with existing RA drug pathways.

bioRxiv · Jan 14, 2025 · PreprintImmunology